HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel approach to devise the therapy for ventricular fibrillation by epicardial delivery of lidocaine using active hydraulic ventricular attaching support system: An experimental study in rats.

Abstract
Active hydraulic ventricular attaching support system (ASD) placed around the heart is not only a novel, nontransplant surgical device used for epicardial administration of drugs like lidocaine, but also a promising treatment option for ventricular fibrillation (VF) and arrhythmias. We hypothesize that lidocaine in 5 mg/kg dose released by ASD significantly improves the VF in the rat model. Sprague-Dawley (SD) rats were selected and were divided into four groups, intravenous injection (IV), epicardial infusion (EI), ASD, and control. ASD group was further divided into four subgroups for different lidocaine doses (i) ASD+A group (10 mg/kg), (ii) ASD+B group (5 mg/kg), (iii) ASD+C group (1 mg/kg), and (iv) ASD+D group (0.1 mg/kg). VF was induced with calcium chloride injection and was confirmed by electrocardiogram (ECG) in all the groups. VF was treated with different doses of lidocaine using different modes of administration. Data were analyzed using the SPSS 19.0 Chi-square tests and one-way analysis of variance (ANOVA). The Kaplan-Meier curve for OS was compared to the Logrank test based on the survival time. P < 0.05 was considered as statistically significant. ASD + B group (5 mg/kg) showed significantly reduced sgroup. The time of first sinus rhythm recovered (15.96 ± 21.77 min) and ▵T-SOD in plasma (-42.02 ± 26.99 U/mL) was significantly different than that of control, IV, and EI groups. ▵T-SOD in plasma for all ASD-treated groups was smaller than the control and IV groups. This study proves that ASD with 5 mg/kg lidocaine dose appears as a promising therapeutic platform for treating VF in rats. Furthermore, ASD may also have potential for treating VF or other cardiovascular disease with different therapeutic agents. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 107B: 1722-1731, 2019.
AuthorsSufia Yasmeen, Xiaoqian Liao, Farhan Ullah Khan, Awais Ullah Ihsan, Xue Li, Cunyu Li, Dingding Chen, Feng Yu, Zhijie Wang, Kiganda Raymond Sembatya, Reyaj Mikrani, Xiaohui Zhou
JournalJournal of biomedical materials research. Part B, Applied biomaterials (J Biomed Mater Res B Appl Biomater) Vol. 107 Issue 5 Pg. 1722-1731 (07 2019) ISSN: 1552-4981 [Electronic] United States
PMID30367819 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2018 Wiley Periodicals, Inc.
Chemical References
  • Drug Carriers
  • Lidocaine
  • Superoxide Dismutase
  • Silicon
Topics
  • Animals
  • Dose-Response Relationship, Drug
  • Drug Carriers (chemistry, metabolism)
  • Drug Liberation
  • Electrocardiography
  • Heart Ventricles (drug effects)
  • Heart-Assist Devices
  • Infusion Pumps
  • Lidocaine (administration & dosage, therapeutic use)
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Silicon (chemistry)
  • Superoxide Dismutase (blood)
  • Treatment Outcome
  • Ventricular Fibrillation (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: